MDXH
MDxHealth S.A. (MDXH) Risks & Opportunities Analysis (2026)
Overall Score
Liquidity Solvency Risk
Current ratio is only 1.08 and quick ratio is 0.94, leaving limited near-term liquidity cushion.
Cash ratio of 0.59 suggests the company is not highly cash-rich relative to short-term obligations.
Negative solvency ratio and high debt-to-assets ratio of 0.64 indicate a stretched balance sheet.
Profitability Cash Flow Risk
TTM EBITDA margin is -7.3% and operating margin is -16.6%, showing ongoing operating losses.
Free cash flow yield is negative and operating cash flow is negative, indicating weak cash generation.
Return on assets is -17.7% and return on invested capital is -12.7%, reflecting poor capital efficiency.
Valuation Dilution Risk
EV/Sales of 1.26 is not demanding on revenue alone, but it is offset by negative earnings and cash flow.
Price-to-book is negative because book value per share is negative, limiting balance-sheet support for valuation.
No dividend is being paid, so shareholders are relying entirely on operational turnaround for returns.
Operating Efficiency Risk
Gross margin remains relatively healthy at 57.7%, but it is not translating into positive operating profit.
Days sales outstanding of 65.9 and cash conversion cycle of 27.8 days suggest working-capital management is acceptable but not enough to offset losses.
SG&A at 40.7% of revenue remains heavy relative to the company’s revenue base.
Sources
- Company filings (10-K, 10-Q, investor presentations)
- Financial and market data providers
- Public news and industry information
🔒 Go Beyond This Framework
This is one of 10 institutional-grade frameworks Invetso runs on MDxHealth S.A.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

